Characterization and Expression of CT45 in Hodgkin's Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Characterization and Expression of CT45 in Hodgkin's Lymphoma

31

Citations

33

References

2006

Year

Hans-Jürgen Heidebrecht, Alexander Claviez, Marie L. Kruse, Marc Pollmann, Friedrich Buck, Sönke Harder, Markus Tiemann, W Dörffel, Reza Parwaresch

Clinical Cancer Research

Abstract

Ki-A10 is the first monoclonal antibody that detects CT45. As benign lymphoid lesions did not express CT45, the use of Ki-A10 antibody will facilitate the discrimination of Hodgkin's lymphoma from reactive lymphadenopathies.

References

	Year	Citations
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. S M Hsu, Laurence Raine, Herbert Fanger Journal of Histochemistry & Cytochemistry ImmunohematologyImmunocytochemical TechniqueImmunologyImmunophenotypingCytoskeleton	1981	14.2K
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues D. K. Hossfeld Annals of Oncology Hematological MalignancyLymphoid NeoplasiaTumoral PathologyLymphoid TissuesCancer Pathology	2002	4.6K
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. Johannes Gerdes, Hilmar Lemke, H. Baisch, The Journal of Immunology Cell RegulationCell DivisionCell Cycle AnalysisCell SignalingMedicine	1984	4.2K
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J L Cordell, Brunangelo Falini, Wendy N. Erber, Journal of Histochemistry & Cytochemistry Immunocytochemical TechniqueImmunologyAlkaline PhosphatasePathologyImmunophenotyping	1984	3.2K
The cancer/testis genes: review, standardization, and commentary. Matthew J. Scanlan, Andrew J.G. Simpson, Lloyd J. Old PubMed Cancer PathologyCt Gene DatabaseImmunologyPathologyCancer/testis Genes	2004	670
DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter Charles De Smet, Christophe Lurquin, Bernard Lethé, Molecular and Cellular Biology	1999	590
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Charles De Smet, Olivier De Backer, Isabella Faraoni, Proceedings of the National Academy of Sciences GeneticsImmunologyTumor CellsCancer BiologyEpigenetics	1996	548
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines Carlo Stresemann, Bodo Brueckner, Tanja Musch, Cancer Research	2006	380
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Jeffrey S. Weber, Michael L. Salgaller, Dvorit Samid, PubMed ImmunologyImmunotherapyCancer BiologyTumor BiologyTumor Immunity	1994	296
Cancer Tumor antigens Thierry Boon, L. Old Current Opinion in Immunology Tumor BiologyTumor ImmunologyCancer Tumor AntigensCancer ImmunosurveillanceImmunoediting	1997	285

Page 1